Kaiser Permanente Division of Research (KP-DOR)
Clinical Research Center
Clinic Director
Steve Sidney, MD
Clinic Manager
Norma Borghi, RN
Clinic Address:
3505 Broadway
Oakland, California 94612
KP-DOR CTSI Coordinator:
Maureen Fitzpatrick, MPH
maureen.b.fitzpatrick@kp.org
(510) 891-3133
KP-DOR CTSI Medical Director (for CTSI studies only)
Joan C. Lo, MD
Joan.C.Lo@kp.org
(510) 891-3682
The Clinic is an outpatient clinical research unit and an accredited procedural sedation site – overseen by the California Department of Health Services, The Joint Commission, Kaiser Permanente Oakland Medical Center’s Department of Quality, and the Department of Accreditation, Regulation and Licensing.
Features:
- 10,000 square feet on two floors.
- 12 interview rooms, three examination rooms, participant changing rooms, bathrooms and showers.
- Designated rooms for bone densitometry expanded monitoring and medical procedures room, secured area for participant charts and study drugs as well as an area to perform EKGs.
- Dual Energy X-ray Absorptiometer (DXA) – A Hologic Discovery Bone Densitometer for studies of osteoporosis in women. This model can acquire scans and perform analysis on AP Lumbar Spine, Left/Right Hip, Left/Right Forearm, Whole Body and AP/Lateral Imaging, and Vertebral Morphometry.
- Three laboratories equipped with refrigerated centrifuges, a –70C countertop freezer and three small refrigerators for interim storage of specimens.
- The main laboratory is equipped with a non-ventilated still air hood, providing enhanced product protection in addition to a fumed hood to ensure occupational and environmental health and safety standards and regulations with chemical usage.
- Negative Pressure processing room for high disinfection.
- Installed Eyewash Stations.
- A designated “Freezer Room” containing -70C freezers, –20C freezers and one refrigerator for short and long-term storage of biological specimens.
- Nearly 50 certified staff members implement clinical study protocols. Designated CLIA (Clinical Laboratory Improvement Amendment) “point of care” testing site.